AZA
AMGN icon

Arthur Zaske & Associates’s Amgen AMGN Stock Holding History

Arthur Zaske & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$372K Buy
2,142
+707
+49% +$125K 0.41% 42
2017
Q3 		$268K Hold
1,435
– – 0.28% 63
2017
Q2 		$247K Hold
1,435
– – 0.22% 63
2017
Q1 		$235K Buy
+1,435
New +$238K 0.17% 63

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arthur Zaske & Associates's AMGN Position: Q4 2017 in Review

Arthur Zaske & Associates increased its Amgen (AMGN) stake by 49% in Q4 2017, buying an estimated $125K and bringing the position to 2,142 shares worth $372K. The position accounts for 0.41% of the portfolio, ranked #42.

Arthur Zaske & Associates first reported a position in AMGN in Q1 2017 and has held it in 4 quarters since. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Arthur Zaske & Associates held 2,142 shares of Amgen worth $372K as of Q4 2017.
  • Arthur Zaske & Associates bought 707 Amgen shares in Q4 2017, an estimated $125K.
  • Amgen made up 0.41% of Arthur Zaske & Associates's portfolio in Q4 2017, its #42 holding.
  • Arthur Zaske & Associates first reported a position in Amgen in Q1 2017 and has held it in 4 quarters since.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Arthur Zaske & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.